Dear Chemo, we need to talk…
What if therapies used to control primary tumor growth increase the likelihood of metastatic relapse?
And how do they impact disseminated cells that have already seeded distant organs at diagnosis?
Why do we need to understand EXTRA-TIME....
What if therapies used to control primary tumor growth increase the likelihood of metastatic relapse?
And how do they impact disseminated cells that have already seeded distant organs at diagnosis?
Why do we need to understand EXTRA-TIME....
✨Highlighting a @CD_AACR Special Issue Commentary for #AACR24 - Chemotherapy and the Extra-tumor Immune Microenvironment: EXTRA-TIME - by @LabPhan, Katherine Weilbaecher, Rebecca Aft, Peter Croucher, and @c_chaffer doi.org/10.1158/2159-8… @GarvanInstitute @UNSWScienceView quoted post on X
